Bulletin
Investor Alert

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 27, 2021, 6:06 p.m.

/zigman2/quotes/210324360/composite

$

225.00

Change

-1.38 -0.61%

Volume

Volume 73,560

Quotes are delayed by 20 min

/zigman2/quotes/210324360/composite

Today's close

$ 206.01

$ 226.38

Change

+20.37 +9.89%

Day low

Day high

$210.44

$226.48

Open

52 week low

52 week high

$136.73

$228.84

Open

Karen T. Dawes

Ms. Karen T. Dawes is an Independent Director at Vaccitech (UK) Ltd., an Independent Director at PaxMedica, Inc., a Chairman at Repligen Corp. and a President at Knowledgeable Decisions LLC. She is on the Board of Directors at Vaccitech (UK) Ltd., PaxMedica, Inc., Medicenna Therapeutics Corp., Symbiomix Therapeutics LLC, Medicines 360, Seaside Therapeutics LLC and Vaccitech Plc. Ms. Dawes was previously employed as an Independent Director by Assertio Therapeutics, Inc., a Chairman by PDL BioPharma, Inc., a Senior Vice President & Head-US Business Group by Bayer Corp., a Senior Vice President by Wyeth Pharmaceuticals, Inc., a Chief Commercial Officer by Genetics Institute, Inc., a Vice President-Marketing by Pfizer Inc., and a Senior Vice President-Global Strategic Marketing by Wyeth Corp. She also served on the board at Inspiration Biopharmaceuticals, Inc., Protein Design Labs, Inc. and Genaissance Pharmaceuticals, Inc. She received her undergraduate degree from Simmons University, a graduate degree from Simmons University and an MBA from Harvard University.

Transactions

Date Shares Transaction Value
07/13/2021 1,520   Disposition at $202.23 per share. 307,389
07/13/2021 2,929   Derivative/Non-derivative trans. at $41.19 per share. 120,645
05/13/2021 604   Award at $0 per share. 0
05/11/2021 285   Disposition at $176.85 per share. 50,403
05/11/2021 15,000   Derivative/Non-derivative trans. at $3.22 per share. 48,300
06/18/2020 2,568   Disposition at $116.56 per share. 299,327
06/18/2020 8,217   Disposition at $115.76 per share. 951,200
06/18/2020 5,243   Disposition at $114.49 per share. 600,272
06/18/2020 2,677   Disposition at $113.58 per share. 304,054
05/20/2020 182   Disposition at $140.29 per share. 25,533
05/20/2020 282   Disposition at $139.4 per share. 39,311
05/20/2020 43   Disposition at $136.98 per share. 5,891
05/20/2020 10   Disposition at $135.91 per share. 1,360
05/18/2020 80   Disposition at $142.45 per share. 11,396
05/18/2020 80   Disposition at $142.45 per share. 11,396
05/18/2020 77   Disposition at $141.45 per share. 10,892
05/18/2020 77   Disposition at $141.45 per share. 10,892
05/18/2020 180   Disposition at $140.62 per share. 25,312
05/18/2020 180   Disposition at $140.62 per share. 25,312
05/18/2020 122   Disposition at $139.32 per share. 16,998
05/18/2020 122   Disposition at $139.32 per share. 16,998
05/18/2020 269   Disposition at $138.6 per share. 37,284
05/18/2020 269   Disposition at $138.6 per share. 37,284
05/18/2020 160   Disposition at $136.92 per share. 21,908
05/18/2020 160   Disposition at $136.92 per share. 21,908
05/18/2020 712   Disposition at $135.76 per share. 96,662
05/18/2020 712   Disposition at $135.76 per share. 96,662
05/13/2020 722   Award at $0 per share. 0
05/13/2020 722   Award at $0 per share. 0
04/21/2020 11,800   Derivative/Non-derivative trans. at $3.3 per share. 38,940
04/21/2020 11,800   Derivative/Non-derivative trans. at $3.3 per share. 38,940
04/20/2020 8,998   Disposition at $104.42 per share. 939,572
04/20/2020 8,998   Disposition at $104.42 per share. 939,572
04/20/2020 3,202   Disposition at $104.98 per share. 336,146
04/20/2020 3,202   Disposition at $104.98 per share. 336,146
04/20/2020 8,200   Derivative/Non-derivative trans. at $3.3 per share. 27,060
04/20/2020 8,200   Derivative/Non-derivative trans. at $3.3 per share. 27,060
02/21/2020 1,849   Disposition at $97.52 per share. 180,315
02/21/2020 906   Disposition at $99.12 per share. 89,803
02/21/2020 945   Disposition at $99.85 per share. 94,359
02/21/2020 300   Disposition at $101.06 per share. 30,318
06/17/2019 1,295   Disposition at $77.35 per share. 100,169
06/17/2019 20,000   Derivative/Non-derivative trans. at $4.96 per share. 99,200
05/15/2019 1,292   Award at $0 per share. 0
05/16/2018 2,080   Award at $0 per share. 0
05/11/2018 20,000   Disposition at $41.8 per share. 836,000
05/11/2018 20,000   Derivative/Non-derivative trans. at $5.08 per share. 101,600
05/18/2017 1,714   Award at $0 per share. 0
03/21/2017 2,521   Disposition at $34.12 per share. 86,017
03/21/2017 20,000   Derivative/Non-derivative trans. at $4.29 per share. 85,800

Officers and Executives

Mr. Tony J. Hunt
President, Chief Executive Officer & Director
Mr. James R. Bylund
Senior Vice President-Global Operations & IT
Mr. Jon K. Snodgres
Chief Financial Officer
Mr. Ralf Kuriyel
Senior Vice President-Research & Development
Mr. Kola Otitoju
Senior VP-Strategy & Business Development
Mr. Squire J. Servance
Secretary, Chief Compliance Officer & Senior VP
Mr. Steve Curran
Vice President-Global Operations
Mr. Vikas Gupta
Vice President-Chromatography
Ms. Christine Gebski
Senior VP-Filtration & Chromatography
Mr. Stephen Tingley
Vice President-Sales
Ms. Rachel Goodrich
Vice President-Marketing
Ms. Sondra S. Newman
Global Head-Investor Relations
Mr. Ken Elmer
Global Head-Human Resources
Ms. Karen T. Dawes
Chairman
Dr. Rohin Mhatre
Independent Director
Ms. Carrie Eglinton Manner
Independent Director
Mr. Thomas F. Ryan
Independent Director
Mr. Nicolas M. Barthelemy
Independent Director
Mr. Glenn P. Muir
Independent Director
Link to MarketWatch's Slice.